This blog post reviews a presentation by Jae Brodowsky, a statistician with the U.S. Food and Drug Administration that put to bed the rumor that FDA will only accept submissions where the data analysis was done by SAS. The summary does mention that FDA has certain regulatory requirements for R (or any other statistical package, including SAS).

Smith D. FDA: R OK for drug trials. R-bloggers. Available at:


This Recommendation was added to the website on 2014-05-30 and was last modified on 2020-02-29. You can find similar pages at R software.

An earlier version of this page appears here.